During the past decade, Charite, Campus Benjamin Franklin, Medizinische Klinik III conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Charite, Campus Benjamin Franklin, Medizinische Klinik III" are "Acute Myeloid Leukemia" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Metastatic Melanoma" (1 trials), "Myelodysplastic Syndrome" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Charite, Campus Benjamin Franklin, Medizinische Klinik III" in a lesser frequency.

Most popular intervention types in "Charite, Campus Benjamin Franklin, Medizinische Klinik III" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-Azacitidine" (1 trials), "Endoxana, IMA901, Leukine" (1 trials), "IMA901 and Leukine" (1 trials), "Lenalidomide" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charite, Campus Benjamin Franklin, Medizinische Klinik III" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Charite, Campus Benjamin Franklin, Medizinische Klinik III". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Charite, Campus Benjamin Franklin, Medizinische Klinik III, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charite, Campus Benjamin Franklin, Medizinische Klinik III, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".